Study protocol for evaluating the efficacy of early pulmonary rehabilitation combined with an internet-based patient management model in patients with COPD: a practical, multicentre, randomised controlled study from China.

IF 4.3 3区 医学 Q1 RESPIRATORY SYSTEM
ERJ Open Research Pub Date : 2024-10-28 eCollection Date: 2024-09-01 DOI:10.1183/23120541.00995-2023
Wang Ye, Li Danye, Cui Jingjing, Zhang Siyu, Wang Jiaxi, Wang Siyuan, Zhao Hongmei, Wang Chen
{"title":"Study protocol for evaluating the efficacy of early pulmonary rehabilitation combined with an internet-based patient management model in patients with COPD: a practical, multicentre, randomised controlled study from China.","authors":"Wang Ye, Li Danye, Cui Jingjing, Zhang Siyu, Wang Jiaxi, Wang Siyuan, Zhao Hongmei, Wang Chen","doi":"10.1183/23120541.00995-2023","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>COPD, a preventable and treatable disease, is characterised by persistent respiratory symptoms and airflow limitations, with high incidence, disability, mortality and disease burden. Currently, drug treatments mainly include bronchodilators and glucocorticoids, which are used to alleviate symptoms and improve lung function. Traditional medical care models and patients' lack of understanding of the disease result in regular and long-term hospitalisations, affect patients' quality of life and cause a need to explore more effective comprehensive intervention plans.</p><p><strong>Methods: </strong>This study is designed as a multicentre, randomised controlled trial consisting of three parallel groups. Group A will receive early pulmonary rehabilitation in the hospital and remote internet pulmonary rehabilitation after discharge. Group B will receive the same early pulmonary rehabilitation in the hospital but outpatient pulmonary rehabilitation after discharge for 8 weeks and routine follow-up management. Group C will receive outpatient pulmonary rehabilitation during a stable period of 3-4 weeks after discharge and routine follow-up management. 1482 patients will be enrolled from 10 centres in China. The primary outcome measures will be the readmission rate due to acute exacerbation at 90 days and the 12-month readmission rate due to acute exacerbation. The secondary outcomes will mainly include differences in all-cause mortality; the number of acute exacerbations; COPD Assessment Test, modified Medical Research Council scale and St George's Respiratory Questionnaire scores; the pulmonary rehabilitation treatment completion rate; patient compliance; and patient and physician satisfaction scores among the three groups at 3, 6 and 12 months after the different interventions. In addition, the proportion of people with ≥2 acute exacerbations within 12 months and the time of the first acute exacerbation will also be included.</p><p><strong>Conclusions: </strong>This study aims to further verify the substitutability of remote internet pulmonary rehabilitation for outpatient rehabilitation and its short-term and long-term effects in patients, providing comprehensive interventional evidence for the treatment of COPD.</p>","PeriodicalId":11739,"journal":{"name":"ERJ Open Research","volume":"10 5","pages":""},"PeriodicalIF":4.3000,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11513996/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ERJ Open Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1183/23120541.00995-2023","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/9/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

Abstract

Background: COPD, a preventable and treatable disease, is characterised by persistent respiratory symptoms and airflow limitations, with high incidence, disability, mortality and disease burden. Currently, drug treatments mainly include bronchodilators and glucocorticoids, which are used to alleviate symptoms and improve lung function. Traditional medical care models and patients' lack of understanding of the disease result in regular and long-term hospitalisations, affect patients' quality of life and cause a need to explore more effective comprehensive intervention plans.

Methods: This study is designed as a multicentre, randomised controlled trial consisting of three parallel groups. Group A will receive early pulmonary rehabilitation in the hospital and remote internet pulmonary rehabilitation after discharge. Group B will receive the same early pulmonary rehabilitation in the hospital but outpatient pulmonary rehabilitation after discharge for 8 weeks and routine follow-up management. Group C will receive outpatient pulmonary rehabilitation during a stable period of 3-4 weeks after discharge and routine follow-up management. 1482 patients will be enrolled from 10 centres in China. The primary outcome measures will be the readmission rate due to acute exacerbation at 90 days and the 12-month readmission rate due to acute exacerbation. The secondary outcomes will mainly include differences in all-cause mortality; the number of acute exacerbations; COPD Assessment Test, modified Medical Research Council scale and St George's Respiratory Questionnaire scores; the pulmonary rehabilitation treatment completion rate; patient compliance; and patient and physician satisfaction scores among the three groups at 3, 6 and 12 months after the different interventions. In addition, the proportion of people with ≥2 acute exacerbations within 12 months and the time of the first acute exacerbation will also be included.

Conclusions: This study aims to further verify the substitutability of remote internet pulmonary rehabilitation for outpatient rehabilitation and its short-term and long-term effects in patients, providing comprehensive interventional evidence for the treatment of COPD.

慢性阻塞性肺疾病患者早期肺康复与互联网患者管理模式相结合的疗效评估研究方案:一项来自中国的实用、多中心、随机对照研究。
背景:慢性阻塞性肺疾病是一种可预防、可治疗的疾病,主要表现为持续性呼吸道症状和气流受限,发病率高、致残率高、死亡率高、疾病负担重。目前,药物治疗主要包括支气管扩张剂和糖皮质激素,用于缓解症状和改善肺功能。传统的医疗护理模式和患者对疾病的不了解导致患者定期和长期住院,影响患者的生活质量,因此需要探索更有效的综合干预方案:本研究设计为多中心随机对照试验,由三个平行小组组成。A 组将在医院接受早期肺康复治疗,出院后接受远程网络肺康复治疗。B 组同样在医院接受早期肺康复治疗,出院后接受为期 8 周的门诊肺康复治疗和常规随访管理。C 组将在出院后的 3-4 周稳定期内接受门诊肺康复治疗,并进行常规随访管理。中国的 10 个中心将招募 1482 名患者。主要结果指标为90天内因急性加重而再次入院的比率和12个月内因急性加重而再次入院的比率。次要结果主要包括全因死亡率、急性加重次数、慢性阻塞性肺病评估测试、改良医学研究委员会量表和圣乔治呼吸系统问卷评分、肺康复治疗完成率、患者依从性以及三组患者在不同干预措施后3、6和12个月的患者和医生满意度评分的差异。此外,12个月内急性加重≥2次的人数比例和首次急性加重的时间也将包括在内:本研究旨在进一步验证远程互联网肺康复对门诊康复的可替代性及其对患者的短期和长期效果,为慢性阻塞性肺疾病的治疗提供全面的干预证据。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
ERJ Open Research
ERJ Open Research Medicine-Pulmonary and Respiratory Medicine
CiteScore
6.20
自引率
4.30%
发文量
273
审稿时长
8 weeks
期刊介绍: ERJ Open Research is a fully open access original research journal, published online by the European Respiratory Society. The journal aims to publish high-quality work in all fields of respiratory science and medicine, covering basic science, clinical translational science and clinical medicine. The journal was created to help fulfil the ERS objective to disseminate scientific and educational material to its members and to the medical community, but also to provide researchers with an affordable open access specialty journal in which to publish their work.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信